Cardiol Therapeutics (CRDL.TO) Q4 2024 Earnings

Nov 14Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.19
-0.16
-0.13
-0.1

Details

Expected EPS
-0.13244858937355503
Actual EPS
-0.18707868270000003
Surprise EPS
-0.05
Surprise Percent
-41.25%

Description

⁨Cardiol Therapeutics⁩ (⁦CRDL.TO⁩) has reported earnings of ⁦-0.18707868270000003⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts